Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.47
+0.20 (0.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 858 | 553 | 114 | - | - | - |
| Market Cap Growth | 1387.49% | 384.71% | - | - | - | - |
| Enterprise Value | 705 | 443 | -52 | - | - | - |
| Last Close Price | 24.47 | 17.80 | 4.23 | - | - | - |
| PB Ratio | 5.17 | 3.66 | 0.75 | - | - | - |
| P/TBV Ratio | 5.68 | 3.66 | 0.75 | - | - | - |
| Debt / Equity Ratio | 0.16 | 0.16 | 0.11 | 0.14 | 0.28 | - |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.00 | -1.02 | -1.08 | -0.95 |
| Net Debt / EBITDA Ratio | 2.32 | 2.32 | 2.22 | 1.94 | 1.33 | 2.16 |
| Net Debt / FCF Ratio | 2.95 | 2.95 | 3.06 | 2.14 | 1.82 | 2.59 |
| Quick Ratio | 15.58 | 15.58 | 16.81 | 14.71 | 8.76 | 15.17 |
| Current Ratio | 15.69 | 15.69 | 16.92 | 15.22 | 8.85 | 15.30 |
| Return on Equity (ROE) | -41.80% | -41.80% | -55.19% | -67.95% | -88.40% | - |
| Return on Assets (ROA) | -22.90% | -22.90% | -32.46% | -34.38% | -45.81% | - |
| Return on Capital Employed (ROCE) | -38.30% | -38.30% | -41.00% | -46.70% | -64.50% | -44.70% |
| Earnings Yield | -7.37% | -11.44% | -53.85% | - | - | - |
| FCF Yield | -6.04% | -9.37% | -43.39% | - | - | - |
| Buyback Yield / Dilution | -17.27% | -17.27% | -559.39% | -8.27% | -42.78% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.